News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
Marvel Biosciences Announces Stock Option Grants
July 26, 2024
·
3 min read
Press Releases
Bachem with Slight Sales Growth in the First Half of 2024. Outlook Confirmed for Full Year
July 25, 2024
·
4 min read
Press Releases
Marvel Announces an Extension to Its Collaboration with The iBraiN Institute to Test MB204 In a Pre-Clinical Model of Rett Syndrome
July 24, 2024
·
5 min read
Press Releases
Defence Therapeutics Granted CNRI-H from the Canadian Nuclear Laboratories to Accelerate the Development of Its Radio-Immuno-Conjugates Program
July 24, 2024
·
5 min read
Press Releases
Fecal Incontinence Market Estimated to Reach USD 3.2 Billion by 2034, Impelled by Sacral Nerve Stimulation Techniques
July 23, 2024
·
10 min read
Press Releases
Optimi Health to Enter Asian Market with PsiloThai Collaboration on Psilocybin Research
July 23, 2024
·
6 min read
Press Releases
Awakn Life Sciences Provides Update on Aminoindane New Chemical Entity Patent Portfolio
July 22, 2024
·
7 min read
Press Releases
Britannia Announces Closing of Offering of Unsecured Debenture Units
July 22, 2024
·
2 min read
Press Releases
NervGen Pharma Appoints Neil Klompas to Board of Directors
July 22, 2024
·
7 min read
Press Releases
Marvel Biosciences Closes Private Placement
July 19, 2024
·
4 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us